Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of Infection With HIV-1”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Early research (Phase 1)Study completedNCT02599896
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
Prevention of HIV InfectionHIV AntibodiesMonoclonal Antibody, Human+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 49
Large-scale testing (Phase 3)Ended earlyNCT04652700
What this trial is testing

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)

Who this might be right for
HIV Preexposure Prophylaxis
Merck Sharp & Dohme LLC 494
Early research (Phase 1)Study completedNCT01127464
What this trial is testing

DCVax Plus Poly ICLC in Healthy Volunteers

Who this might be right for
HIV-1 InfectionHIV InfectionHealthy Volunteers
Rockefeller University 43
Large-scale testing (Phase 3)Ended earlyNCT00409591
What this trial is testing

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand

Who this might be right for
HIV InfectionsPregnancy
Institut de Recherche pour le Developpement 435
Large-scale testing (Phase 3)WithdrawnNCT01337570
What this trial is testing

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc.
Early research (Phase 1)Study completedNCT01292174
What this trial is testing

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

Who this might be right for
Prevention of Infection With HIV-1
TaiMed Biologics Inc. 25
Large-scale testing (Phase 3)WithdrawnNCT01337583
What this trial is testing

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc.
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Post-approval studies (Phase 4)Study completedNCT00144157
What this trial is testing

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

Who this might be right for
Acquired Immunodeficiency Syndrome
Boehringer Ingelheim 53
Testing effectiveness (Phase 2)Study completedNCT00405821
What this trial is testing

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Who this might be right for
HIV InfectionsHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 440
Post-approval studies (Phase 4)Study completedNCT00594646
What this trial is testing

HIV Non Occupational Post-Exposure Prophylaxis (PEP)

Who this might be right for
HIV Infections
Fenway Community Health 100
Testing effectiveness (Phase 2)WithdrawnNCT03074786
What this trial is testing

Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)

Who this might be right for
HIV-1-infection
International Partnership for Microbicides, Inc.
Not applicableStudy completedNCT04661813
What this trial is testing

Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV

Who this might be right for
HIV-1-infectionHypertension
Case Western Reserve University 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06626555
What this trial is testing

Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection

Who this might be right for
HIV
University College, London 36
Early research (Phase 1)Study completedNCT00984971
What this trial is testing

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

Who this might be right for
HIV PreventionHIV Infections
CONRAD 18
Not applicableLooking for participantsNCT06900829
What this trial is testing

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

Who this might be right for
HIV InfectionHIVStigma+3 more
Casper Rokx 5,200
Large-scale testing (Phase 3)Ended earlyNCT02842086
What this trial is testing

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV-1 Infection
Gilead Sciences 5,399
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Early research (Phase 1)Study completedNCT03783130
What this trial is testing

Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults

Who this might be right for
Human Immunodeficiency Virus PreventionHuman Immunodeficiency Virus (HIV)
National Institute of Allergy and Infectious Diseases (NIAID) 16
Large-scale testing (Phase 3)Study completedNCT00640263
What this trial is testing

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 1,500
Next Page